0 XP   0   0   0

RAPT Therapeutics Inc
Buy, Hold or Sell?

I guess you are interested in RAPT Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Rapt

Let's start. I'm going to help you getting a better view of RAPT Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is RAPT Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how RAPT Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value RAPT Therapeutics Inc. The closing price on 2022-09-30 was $24.06 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
RAPT Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of RAPT Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Rapt earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rapt to the Biotechnology industry mean.
  • A Net Profit Margin of -2,415.2% means that $-24.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RAPT Therapeutics Inc:

  • The MRQ is -2,165.2%. The company is making a huge loss. -2
  • The TTM is -2,415.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,165.2%TTM-2,415.2%+249.9%
TTM-2,415.2%YOY-1,040.9%-1,374.2%
TTM-2,415.2%5Y-1,080.0%-1,335.2%
5Y-1,080.0%10Y-1,080.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,165.2%-242.4%-1,922.8%
TTM-2,415.2%-275.9%-2,139.3%
YOY-1,040.9%-342.1%-698.8%
5Y-1,080.0%-475.7%-604.3%
10Y-1,080.0%-561.7%-518.3%
1.1.2. Return on Assets

Shows how efficient Rapt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rapt to the Biotechnology industry mean.
  • -9.3% Return on Assets means that Rapt generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RAPT Therapeutics Inc:

  • The MRQ is -8.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-9.3%+0.6%
TTM-9.3%YOY-8.5%-0.8%
TTM-9.3%5Y-10.9%+1.6%
5Y-10.9%10Y-10.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-9.7%+1.1%
TTM-9.3%-8.7%-0.6%
YOY-8.5%-9.2%+0.7%
5Y-10.9%-11.5%+0.6%
10Y-10.9%-12.4%+1.5%
1.1.3. Return on Equity

Shows how efficient Rapt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rapt to the Biotechnology industry mean.
  • -9.5% Return on Equity means the company generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RAPT Therapeutics Inc:

  • The MRQ is -9.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-10.1%+0.6%
TTM-10.1%YOY-9.7%-0.5%
TTM-10.1%5Y-10.0%-0.1%
5Y-10.0%10Y-10.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.5%-11.8%+2.3%
TTM-10.1%-11.1%+1.0%
YOY-9.7%-10.6%+0.9%
5Y-10.0%-13.5%+3.5%
10Y-10.0%-14.5%+4.5%

1.2. Operating Efficiency of RAPT Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rapt is operating .

  • Measures how much profit Rapt makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rapt to the Biotechnology industry mean.
  • An Operating Margin of -2,165.2% means the company generated $-21.65  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RAPT Therapeutics Inc:

  • The MRQ is -2,165.2%. The company is operating very inefficient. -2
  • The TTM is -2,415.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,165.2%TTM-2,415.2%+249.9%
TTM-2,415.2%YOY-1,032.4%-1,382.7%
TTM-2,415.2%5Y-1,074.6%-1,340.5%
5Y-1,074.6%10Y-1,074.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,165.2%-232.1%-1,933.1%
TTM-2,415.2%-269.6%-2,145.6%
YOY-1,032.4%-309.3%-723.1%
5Y-1,074.6%-466.7%-607.9%
10Y-1,074.6%-572.5%-502.1%
1.2.2. Operating Ratio

Measures how efficient Rapt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2,234.2% means that the operating costs are $22.34for each $1 in net sales.

Let's take a look of the Operating Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is 22.342. The company is inefficient in keeping operating costs low. -1
  • The TTM is 25.199. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ22.342TTM25.199-2.857
TTM25.199YOY13.913+11.286
TTM25.1995Y12.146+13.053
5Y12.14610Y12.1460.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.3423.321+19.021
TTM25.1993.542+21.657
YOY13.9133.491+10.422
5Y12.1465.744+6.402
10Y12.1467.007+5.139

1.3. Liquidity of RAPT Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rapt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1,596.9% means the company has $15.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is 15.969. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.797. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.969TTM16.797-0.828
TTM16.797YOY12.259+4.539
TTM16.7975Y13.226+3.571
5Y13.22610Y13.2260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.9695.266+10.703
TTM16.7976.060+10.737
YOY12.2596.366+5.893
5Y13.2266.692+6.534
10Y13.2266.457+6.769
1.3.2. Quick Ratio

Measures if Rapt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 2,719.3% means the company can pay off $27.19 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is 27.193. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 29.519. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ27.193TTM29.519-2.326
TTM29.519YOY20.360+9.158
TTM29.5195Y17.783+11.735
5Y17.78310Y17.7830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.1934.055+23.138
TTM29.5194.865+24.654
YOY20.3605.192+15.168
5Y17.7835.275+12.508
10Y17.7834.997+12.786

1.4. Solvency of RAPT Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rapt assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.09 means that Rapt assets are financed with 8.9% credit (debt) and the remaining percentage (100% - 8.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is 0.089. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.082. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.082+0.007
TTM0.082YOY0.116-0.034
TTM0.0825Y0.471-0.389
5Y0.47110Y0.4710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0890.271-0.182
TTM0.0820.269-0.187
YOY0.1160.296-0.180
5Y0.4710.361+0.110
10Y0.4710.399+0.072
1.4.2. Debt to Equity Ratio

Measures if Rapt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 9.8% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is 0.098. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.090. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.098TTM0.090+0.009
TTM0.090YOY0.133-0.043
TTM0.0905Y0.283-0.194
5Y0.28310Y0.2830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0980.310-0.212
TTM0.0900.311-0.221
YOY0.1330.310-0.177
5Y0.2830.382-0.099
10Y0.2830.438-0.155

2. Market Valuation of RAPT Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Rapt.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -7.16 means the investor is paying $-7.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RAPT Therapeutics Inc:

  • The EOD is -9.444. Company is losing money. -2
  • The MRQ is -7.164. Company is losing money. -2
  • The TTM is -10.733. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-9.444MRQ-7.164-2.281
MRQ-7.164TTM-10.733+3.570
TTM-10.733YOY-11.136+0.403
TTM-10.7335Y-6.195-4.539
5Y-6.19510Y-6.1950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.444-2.115-7.329
MRQ-7.164-2.332-4.832
TTM-10.733-3.889-6.844
YOY-11.136-5.087-6.049
5Y-6.195-3.697-2.498
10Y-6.195-3.390-2.805
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Rapt.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of RAPT Therapeutics Inc:

  • The MRQ is -1.290. Very Bad. -2
  • The TTM is 0.146. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-1.290TTM0.146-1.436
TTM0.146YOY0.133+0.013
TTM0.1465Y0.139+0.006
5Y0.13910Y0.1390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.2900.003-1.293
TTM0.1460.019+0.127
YOY0.1330.042+0.091
5Y0.1390.020+0.119
10Y0.1390.017+0.122

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Rapt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.81 means the investor is paying $2.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of RAPT Therapeutics Inc:

  • The EOD is 3.707. Neutral. Compare to industry.
  • The MRQ is 2.812. Good. +1
  • The TTM is 4.261. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.707MRQ2.812+0.895
MRQ2.812TTM4.261-1.449
TTM4.261YOY5.387-1.126
TTM4.2615Y3.591+0.670
5Y3.59110Y3.5910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.7071.843+1.864
MRQ2.8121.961+0.851
TTM4.2612.789+1.472
YOY5.3873.538+1.849
5Y3.5912.782+0.809
10Y3.5912.419+1.172

2.4. Latest News of RAPT Therapeutics Inc

Does RAPT Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from RAPT Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-23
18:00
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should KnowRead
2022-09-23
15:55
Here's Why Rapt Therapeutics (RAPT) Looks Ripe for Bottom FishingRead
2022-09-15
12:17
Quite a few insiders invested in RAPT Therapeutics, Inc. (NASDAQ:RAPT) last year which is positive news for shareholdersRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of RAPT Therapeutics Inc.

3.1. Institutions holding RAPT Therapeutics Inc

Institutions are holding 103.248% of the shares of RAPT Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31T. Rowe Price Associates, Inc.13.40570.00883974705270200.6845
2022-03-31FMR Inc10.73440.0056318270193386841.5268
2022-03-31Perceptive Advisors LLC9.44361.23332799962-3055168-52.1793
2022-06-30Column Group LLC9.040510.41112680458127845091.1871
2022-06-30Ponoi Management, LLC5.394446.0852159941700
2022-03-31State Street Corporation4.5450.001513475811037948.345
2022-06-30KPCB XV Associates LLC4.374743.6581129706300
2022-03-31Vanguard Group Inc4.13010.00061224545181931.5081
2022-03-31Kingdon Capital Management LLC3.67062.49421088321-60000-5.225
2022-03-31Morgan Stanley - Brokerage Accounts3.56150.00311055957560845.6091
2022-03-31Redmile Group, LLC2.52510.51397486777486770
2022-06-30Regents Of The University Of California1.49621.62244361900
2022-06-30Euclidean Capital LLC1.46016.719143290000
2022-03-31Geode Capital Management, LLC1.24990.001370591265777.7256
2022-03-31Orbimed Advisors, LLC1.21860.128836130014430066.4977
2022-03-31Woodline Partners LP1.20890.1283584433584430
2022-03-31Wellington Management Company LLP1.02090.0011302682-1067635-77.9115
2022-03-31Deutsche Bank AG0.97250.003288336-23495-7.5345
2022-03-31Dimensional Fund Advisors, Inc.0.96230.00192853256923832.0417
2022-03-31Healthcor Management LP0.89090.38752641508275045.6174
Total 81.3059113.407824106733  

3.2. Funds holding RAPT Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30T. Rowe Price New Horizons5.5410.1301164289126572419.295
2022-06-30Strategic Advisers® Fidelity US TtlStk5.51390.04721634849-17271-1.0454
2022-06-30Fidelity® Select Biotechnology3.75450.4183111317700
2022-07-31Vanguard Total Stock Mkt Idx Inv2.54380.001175421700
2022-06-30T. Rowe Price Health Sciences2.3370.0815692900-77912-10.1078
2022-07-29iShares Russell 2000 ETF1.85960.0195513604800.0871
2022-06-30T. Rowe Price Small-Cap Stock1.62540.1031481922-2200-0.4544
2022-03-31FIAM Small Cap Core Class B0.98590.1724292300150275105.8088
2022-03-31FIAM Small Cap Core Composite0.98590.1768292300150275105.8088
2022-07-31Xtrackers LPX Private Equity Swap ETF 1C0.92691.631927483200
2022-07-31Vanguard Extended Market Index Investor0.90290.00572676974900.1834
2022-06-30Candriam Eqs L Biotech C USD Cap0.89170.300426438500
2022-06-30T. Rowe Price US Small-Cap Core Equity0.88360.1055261979-4949-1.8541
2022-06-30T. Rowe Price Instl Small-Cap Stock0.88360.1055261979-4949-1.8541
2022-06-30T. Rowe Price New Horizons Tr-Z0.81150.15212405996448436.6147
2022-03-31FIAM Small/Mid Cap Core II0.79930.576223700010970086.1744
2022-04-30Biotech Growth Ord0.73190.712721700000
2022-06-30T. Rowe Price U.S. SC Core Eq Tr-Z0.66110.113519600422001.1352
2022-07-29iShares Biotechnology ETF0.60810.0414180302-278-0.1539
2022-06-30BlackRock Health Sciences Trust II0.60220.153417854500
Total 33.84985.047810036238  

3.3. Insider Transactions

Insiders are holding 2.481% of the shares of RAPT Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-07-11William HoSELL200019.9552306
2022-05-25Group Ii Lp ColumnBUY190012.451236261
2022-05-23Group Ii Lp ColumnBUY1023612.51218648
2022-05-10Group Ii Lp ColumnBUY125000010.671208750
2022-05-10Rodney Kb YoungBUY500010.5310084
2022-05-10Wendye RobbinsBUY450011.2413800
2022-05-04Dirk G BrockstedtSELL72015.0519812
2022-04-11Dirk G BrockstedtSELL264723.0519812
2022-04-06William HoSELL300022.96
2022-03-11Dirk G BrockstedtSELL264823.91
2022-02-28William HoSELL300018.79
2022-02-11Dirk G BrockstedtSELL264722.47
2022-01-13William HoSELL300030.67
2022-01-11Dirk G BrockstedtSELL264832.16
2022-01-05William HoSELL200040
2021-12-10Dirk G BrockstedtSELL264730.88
2021-12-03William HoSELL300032.26
2021-11-11Dirk G BrockstedtSELL264835.69
2021-10-18Wendye RobbinsBUY50030.7
2021-10-13Wendye RobbinsBUY40029.69

4. Summary

4.1. Key Performance Indicators

The key performance indicators of RAPT Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--6.4916.330+3%5.238+24%-6.228+196%-6.228+196%
Book Value Per Share Growth--0.816-0.503+162%0.866-6%0.433+88%0.433+88%
Current Ratio--15.96916.797-5%12.259+30%13.226+21%13.226+21%
Debt To Asset Ratio--0.0890.082+9%0.116-23%0.471-81%0.471-81%
Debt To Equity Ratio--0.0980.090+10%0.133-26%0.283-65%0.283-65%
Dividend Per Share----0%-0%-0%-0%
Eps---0.616-0.637+3%-0.603-2%-1.494+142%-1.494+142%
Eps Growth--5.5537.297-24%-83.858+1610%-38.280+789%-38.280+789%
Gains Per Share--0.816-0.503+162%0.866-6%0.433+88%0.433+88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---21.652-24.152+12%-10.409-52%-10.800-50%-10.800-50%
Operating Margin---21.652-24.152+12%-10.324-52%-10.746-50%-10.746-50%
Operating Ratio--22.34225.199-11%13.913+61%12.146+84%12.146+84%
Pb Ratio3.707+24%2.8124.261-34%5.387-48%3.591-22%3.591-22%
Pe Ratio-9.444-32%-7.164-10.733+50%-11.136+55%-6.195-14%-6.195-14%
Peg Ratio---1.2900.146-987%0.133-1071%0.139-1027%0.139-1027%
Price Per Share24.060+24%18.25027.005-32%26.485-31%19.457-6%19.457-6%
Quick Ratio--27.19329.519-8%20.360+34%17.783+53%17.783+53%
Return On Assets---0.086-0.093+7%-0.085-2%-0.109+27%-0.109+27%
Return On Equity---0.095-0.101+7%-0.097+2%-0.100+5%-0.100+5%
 EOD+1 -2MRQTTM+12 -6YOY+10 -85Y+15 -310Y+15 -3

4.2. Fundamental Score

Let's check the fundamental score of RAPT Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.444
Price to Book Ratio (EOD)Between0-13.707
Net Profit Margin (MRQ)Greater than0-21.652
Operating Margin (MRQ)Greater than0-21.652
Quick Ratio (MRQ)Greater than127.193
Current Ratio (MRQ)Greater than115.969
Debt to Asset Ratio (MRQ)Less than10.089
Debt to Equity Ratio (MRQ)Less than10.098
Return on Equity (MRQ)Greater than0.15-0.095
Return on Assets (MRQ)Greater than0.05-0.086
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of RAPT Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.294
Ma 20Greater thanMa 5024.715
Ma 50Greater thanMa 10024.491
Ma 100Greater thanMa 20020.591
OpenGreater thanClose23.870
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets221,996
Total Liabilities19,863
Total Stockholder Equity202,133
 As reported
Total Liabilities 19,863
Total Stockholder Equity+ 202,133
Total Assets = 221,996

Assets

Total Assets221,996
Total Current Assets209,929
Long-term Assets209,929
Total Current Assets
Cash And Cash Equivalents 57,203
Short-term Investments 150,138
Other Current Assets 2,588
Total Current Assets  (as reported)209,929
Total Current Assets  (calculated)209,929
+/-0
Long-term Assets
Property Plant Equipment 8,976
Other Assets 3,091
Long-term Assets  (as reported)12,067
Long-term Assets  (calculated)12,067
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,146
Long-term Liabilities6,717
Total Stockholder Equity202,133
Total Current Liabilities
Short-term Debt 1,503
Accounts payable 4,097
Other Current Liabilities 7,546
Total Current Liabilities  (as reported)13,146
Total Current Liabilities  (calculated)13,146
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,717
Long-term Liabilities  (as reported)6,717
Long-term Liabilities  (calculated)6,717
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -323,698
Accumulated Other Comprehensive Income -745
Capital Surplus 526,573
Total Stockholder Equity (as reported)202,133
Total Stockholder Equity (calculated)202,133
+/-0
Other
Capital Stock3
Cash and Short Term Investments 207,341
Common Stock Shares Outstanding 31,140
Common Stock Total Equity3
Liabilities and Stockholders Equity 221,996
Net Debt -48,983
Net Invested Capital 202,133
Net Tangible Assets 202,133
Net Working Capital 196,783
Short Long Term Debt Total 8,220



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
69,610
67,860
68,109
58,369
84,602
150,889
139,676
128,970
118,969
105,924
231,081
217,462
198,636
187,548
221,996
221,996187,548198,636217,462231,081105,924118,969128,970139,676150,88984,60258,36968,10967,86069,610000
   > Total Current Assets 
0
0
0
65,062
63,224
62,056
51,224
80,506
146,894
136,077
125,508
115,598
102,606
227,955
214,495
192,973
175,664
209,929
209,929175,664192,973214,495227,955102,606115,598125,508136,077146,89480,50651,22462,05663,22465,062000
       Cash And Cash Equivalents 
0
0
0
63,798
61,758
59,862
48,310
77,383
91,529
28,957
20,229
24,918
24,720
86,220
59,999
24,027
32,418
57,203
57,20332,41824,02759,99986,22024,72024,91820,22928,95791,52977,38348,31059,86261,75863,798000
       Short-term Investments 
0
0
0
0
0
0
0
0
46,670
103,993
102,557
86,592
73,686
137,084
150,787
165,627
140,590
150,138
150,138140,590165,627150,787137,08473,68686,592102,557103,99346,67000000000
       Net Receivables 
0
0
0
0
0
0
0
0
5,010
0
0
0
0
0
0
0
0
0
0000000005,01000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
2,722
4,088
4,200
4,651
3,709
3,319
2,656
2,588
2,5882,6563,3193,7094,6514,2004,0882,7220000000000
   > Long-term Assets 
0
0
0
4,548
4,636
6,053
7,145
4,096
3,995
3,599
3,462
3,371
3,318
3,126
2,967
5,663
11,884
12,067
12,06711,8845,6632,9673,1263,3183,3713,4623,5993,9954,0967,1456,0534,6364,548000
       Property Plant Equipment 
0
0
0
4,159
4,247
4,277
4,002
3,707
3,606
3,210
3,073
2,982
2,929
2,737
2,578
2,741
8,951
8,976
8,9768,9512,7412,5782,7372,9292,9823,0733,2103,6063,7074,0024,2774,2474,159000
       Other Assets 
0
0
0
0
389
1,776
3,143
389
389
389
389
389
389
389
389
2,922
2,933
3,091
3,0912,9332,9223893893893893893893893893,1431,7763890000
> Total Liabilities 
0
0
0
5,612
173,611
8,103
183,166
11,481
18,960
17,065
18,923
14,790
14,283
13,502
15,589
12,256
19,713
19,863
19,86319,71312,25615,58913,50214,28314,79018,92317,06518,96011,481183,1668,103173,6115,612000
   > Total Current Liabilities 
0
0
0
4,643
3,471
5,895
5,457
9,256
13,442
13,080
15,591
11,742
11,143
10,394
12,695
9,595
12,360
13,146
13,14612,3609,59512,69510,39411,14311,74215,59113,08013,4429,2565,4575,8953,4714,643000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,481
1,503
1,5031,4810000000000000000
       Accounts payable 
0
0
0
0
1,320
2,604
1,590
1,143
3,409
2,381
4,405
2,383
3,131
2,714
4,017
1,999
1,936
4,097
4,0971,9361,9994,0172,7143,1312,3834,4052,3813,4091,1431,5902,6041,3200000
       Other Current Liabilities 
0
0
0
0
470
459
457
4,471
6,201
6,443
6,058
5,263
4,877
5,397
7,140
6,580
8,298
7,546
7,5468,2986,5807,1405,3974,8775,2636,0586,4436,2014,4714574594700000
   > Long-term Liabilities 
0
0
0
969
170,140
2,208
177,709
2,225
5,518
3,985
3,332
3,048
3,140
3,108
2,894
2,661
7,353
6,717
6,7177,3532,6612,8943,1083,1403,0483,3323,9855,5182,225177,7092,208170,140969000
       Other Liabilities 
0
0
0
0
2,082
2,208
2,219
2,225
5,518
3,985
3,332
3,048
3,140
3,108
2,894
2,661
241
0
02412,6612,8943,1083,1403,0483,3323,9855,5182,2252,2192,2082,0820000
       Deferred Long Term Liability 
0
0
0
0
0
0
2,800
0
0
0
0
3,048
3,140
3,108
2,894
2,661
241
0
02412,6612,8943,1083,1403,04800002,800000000
> Total Stockholder Equity
-62,405
0
0
0
62,307
60,006
-124,797
73,121
131,929
122,611
110,047
104,179
91,641
217,579
201,873
186,380
167,835
202,133
202,133167,835186,380201,873217,57991,641104,179110,047122,611131,92973,121-124,79760,00662,307000-62,405
   Common Stock
0
0
0
0
1
1
1
2
2
2
2
2
2
3
3
3
3
3
333332222221110000
   Retained Earnings Total Equity-323,698-304,514-284,046-266,117-247,466-231,356-214,84200000000000
   Accumulated Other Comprehensive Income 
0
0
0
-4,969
-5,300
-5,612
-5,834
-6,059
-6,258
-6,603
-6,866
-177
-189
-137
45
-206
-1,117
-745
-745-1,117-20645-137-189-177-6,866-6,603-6,258-6,059-5,834-5,612-5,300-4,969000
   Capital Surplus 
0
0
0
0
22,884
23,265
23,923
235,049
307,009
0
0
319,196
323,184
465,179
467,942
470,629
473,463
526,573
526,573473,463470,629467,942465,179323,184319,19600307,009235,04923,92323,26522,8840000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
-495
-2
13
20
7
177
319,018
104,354
323,184
465,179
467,942
470,629
473,463
526,573
526,573473,463470,629467,942465,179323,184104,354319,01817772013-2-4950000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue3,813
Cost of Revenue--
Gross Profit3,8133,813
 
Operating Income (+$)
Gross Profit3,813
Operating Expense-73,022
Operating Income-69,209-69,209
 
Operating Expense (+$)
Research Development56,985
Selling General Administrative16,037
Selling And Marketing Expenses-
Operating Expense73,02273,022
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-69,209
Net Interest Income-
Other Non-Operating Income Expenses5
Income Before Tax (EBT)-69,204-69,214
EBIT - interestExpense = -69,204
-69,204
-69,204
Interest Expense-
Earnings Before Interest and Taxes (ebit)-69,204-69,204
Earnings Before Interest and Taxes (ebitda)-68,208
 
After tax Income (+$)
Income Before Tax-69,204
Tax Provision-0
Net Income From Continuing Ops-69,204-69,204
Net Income-69,204
Net Income Applicable To Common Shares-69,204
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses73,022
Total Other Income/Expenses Net5-5
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
5 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
5 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
5 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
5 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
5 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
5 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
5 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart